NovaBridge Biosciences (NBP) Interest Expenses (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Interest Expenses for 8 consecutive years, with $253000.0 the latest figure, recorded in Q4 2025.

• Quarterly Interest Expenses rose 7.2% year-over-year to $253000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (up 54.29% YoY) and the FY2025 annual result came in at $76.4 million, up 36.32% from the prior year.
• Interest Expenses slipped to $253000.0 in Q4 2025 per NBP's latest filing, from $19.0 million in the prior quarter.
• Over the last five years, Interest Expenses for NBP reached as high as $165.4 million in Q4 2023 and fell as low as $230000.0 in Q3 2024.
• A 5-year average of $45.8 million and a median of $8.2 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2021 — Interest Expenses soared 41331.48% — and 2024, when it sank 99.86%.
• Year by year, Interest Expenses stood at $77.1 million in 2021, then soared by 77.17% to $136.7 million in 2022, then rose by 21.03% to $165.4 million in 2023, then plunged by 99.86% to $236000.0 in 2024, then advanced by 7.2% to $253000.0 in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $253000.0, $19.0 million, and $4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.